The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged &#8805;50 years: A randomized trial.

Min, Ji-Young; Mwakingwe-Omari, Agnes; Riley, Megan; Molo, Lifeter Yenwo; Soni, Jyoti; Girard, Ginette; Danier, Jasur

The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged ≥50 years: A randomized trial.

Min, Ji-Young; Mwakingwe-Omari, Agnes; Riley, Megan; Molo, Lifeter Yenwo; Soni, Jyoti; Girard, Ginette; Danier, Jasur.

Afiliação

Min JY; GSK, 14200 Shady Grove Rd., Rockville, MD, United States.
Mwakingwe-Omari A; GSK, 14200 Shady Grove Rd., Rockville, MD, United States. Electronic address: agnes.x.mwakingwe-omari@gsk.com.
Riley M; GSK, 14200 Shady Grove Rd., Rockville, MD, United States.
Molo LY; GSK, Avenue Fleming 20, 1300 Wavre, Belgium.
Soni J; GSK, Level 4, Prestige Trade Tower, 46, Palace Road, Sampangi Rama Nagar, Bengaluru, Karnataka 560001, India.
Girard G; DIEX Recherche Sherbrooke, Sherbrooke, QC, Canada.
Danier J; GSK, 14200 Shady Grove Rd., Rockville, MD, United States. Electronic address: jasur.x.danier@gsk.com.

J Infect ; 84(4): 490-498, 2022 04.

Article em En | MEDLINE | ID: mdl-34963639

Assuntos

Vacina contra Herpes Zoster; Herpes Zoster; Infecções Pneumocócicas; Adulto; Herpes Zoster/prevenção & controle; Herpesvirus Humano 3; Humanos; Infecções Pneumocócicas/prevenção & controle; Vacinas Pneumocócicas; Vacinas Conjugadas; Vacinas Sintéticas/efeitos adversos

Palavras-chave

13-Valent pneumococcal conjugate vaccine; Co-administration; Immune response; Recombinant zoster vaccine; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacina contra Herpes Zoster / Herpes Zoster Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google